In vitro activities of nisin and nisin derivatives alone and in combination with antibiotics against Staphylococcus biofilms

Frontiers in Microbiology

Volumn 7, Issue APR, 2016, Pages

  Field, Des ^a   O'Connor, Rory ^a   Cotter, Paul D ^b,c   Ross, R Paul ^a   Hill, Colin ^a,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antibiotics; Antimicrobial peptide; Bacterial resistance; Bacteriocin; Biofilm; Lantibiotic; Nisin; Staphylococci

Indexed keywords

ANTIBIOTIC AGENT; NISIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; BOVINE MASTITIS; COLORIMETRY; CONFOCAL MICROSCOPY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS; STREPTOCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS; XTT ASSAY;

EID: 84966292088     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00508     Document Type: Article

References (60)

1. Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., and Shirtliff, M. E. (2011). Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2, 445-459. doi: 10.4161/viru.2.5.17724
2. Bierbaum, G., and Sahl, H. G. (2009). Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10, 2-18. doi: 10.2174/138920109787048616
3. Breukink, E., and de Kruijff, B. (1999). The lantibiotic nisin, a special case or not? Biochim. Biophys. Acta 1462, 223-234. doi: 10.1016/S0005-2736(99)00208-4
4. Brumfitt, W., Salton, M. R., and Hamilton-Miller, J. M. (2002). Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J. Antimicrob. Chemother. 50, 731-734. doi: 10.1093/jac/dkf190
5. Buommino, E., Scognamiglio, M., Donnarumma, G., Fiorentino, A., and D'Abrosca, B. (2014). Recent advances in natural product-based anti-biofilm approaches to control infections. Mini Rev. Med. Chem. 14, 1169-1182. doi: 10.2174/1389557515666150101095853
6. Cavera, V. L., Arthur, T. D., Kashtanov, D., and Chikindas, M. L. (2015a). Bacteriocins and their position in the next wave of conventional antibiotics. Int. J. Antimicrob. Agents 46, 494-501. doi: 10.1016/j.ijantimicag.2015.07.011
7. Cavera, V. L., Volski, A., and Chikindas, M. L. (2015b). The natural antimicrobial subtilosin a synergizes with lauramide arginine ethyl Ester (LAE), epsilon-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis. Probiotics Antimicrob Proteins 7, 164-171. doi: 10.1007/s12602-014-9183-1
8. Chambers, H. F., and Deleo, F. R. (2009). Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629-641. doi: 10.1038/nrmicro2200
9. Chatterjee, C., Paul, M., and Xie, L. (2005). Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105, 633-684. doi: 10.1021/cr030105v
10. Corbin, A., Pitts, B., Parker, A., and Stewart, P. S. (2011). Antimicrobial penetration and efficacy in an in vitro oral biofilm model. Antimicrob. Agents Chemother. 55, 3338-3344. doi: 10.1128/AAC.00206-11
11. Cotter, P. D., Hill, C., and Ross, R. P. (2005a). Bacterial lantibiotics: strategies to improve therapeutic potential. Curr. Protein Pept. Sci. 6, 61-75. doi: 10.2174/1389203053027584
12. Cotter, P. D., Hill, C., and Ross, R. P. (2005b). Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3, 777-788. doi: 10.1038/nrmicro1273
13. Cotter, P. D., Ross, R. P., and Hill, C. (2013). Bacteriocins-a viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95-105. doi: 10.1038/nrmicro2937
14. Cramton, S. E., Gerke, C., Schnell, N. F., Nichols, W. W., and Götz, F. (1999). The Intercellular Adhesion (ica) locus is present in Staphylococcus aureus and Is Required for Biofilm Formation. Infect. Immun. 67, 5427-5433
15. Darouiche, R. O., Dhir, A., Miller, A. J., Landon, G. C., Raad, I. I., and Musher, D. M. (1994). Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J. Infect. Dis. 170, 720-723. doi: 10.1093/infdis/170.3.720
16. Davison, W. M., Pitts, B., and Stewart, P. S. (2010). Spatial and temporal patterns of biocide action against Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 54, 2920-2927. doi: 10.1128/AAC.01734-09
17. Delves-Broughton, J., Blackburn, P., Evans, R. J., and Hugenholtz, J. (1996). Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 69, 193-202. doi: 10.1007/BF00399424
18. Devriese, L. A., Vancanneyt, M., Baele, M., Vaneechoutte, M., De Graef, E., Snauwaert, C., et al. (2005). Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int. J. Syst. Evol. Microbiol. 55, 1569-1573. doi: 10.1099/ijs.0.63413-0
19. Dosler, S., and Gerceker, A. A. (2011). In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus Strains. Chemotherapy 57, 511-516. doi: 10.1159/000335598
20. Dosler, S., and Gerceker, A. A. (2012). In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria. J. Chemother. 24, 137-143. doi: 10.1179/1973947812y.0000000007
21. Dosler, S., and Mataraci, E. (2013). In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms. Peptides 49, 53-58. doi: 10.1016/j.peptides.2013.08.008
22. Field, D., Begley, M., O'Connor, P. M., Daly, K. M., Hugenholtz, F., Cotter, P. D., et al. (2012). Bioengineered nisin a derivatives with enhanced activity against both gram positive and gram negative pathogens. PLoS ONE 7:e46884. doi: 10.1371/journal.pone.0046884
23. Field, D., Cotter, P. D., Ross, R. P., and Hill, C. (2015a). Bioengineering of the model lantibiotic nisin. Bioengineered 6, 187-192. doi: 10.1080/21655979.2015.1049781
24. Field, D., Gaudin, N., Lyons, F., O'Connor, P. M., Cotter, P. D., Hill, C., et al. (2015b). A Bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius. PLoS ONE 10:e0119684. doi: 10.1371/journal.pone.0119684
25. Field, D., O'Connor, P. M., Cotter, P. D., Hill, C., and Ross, R. P. (2008). The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol. Microbiol. 69, 218-230. doi: 10.1111/j.1365-2958.2008.06279.x
26. Field, D., Quigley, L., O'Connor, P. M., Rea, M. C., Daly, K., Cotter, P. D., et al. (2010). Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V. Microb Biotechnol. 3, 473-486. doi: 10.1111/j.1751-7915.2010.00184.x
27. Fitzgerald, J. R., Meaney, W. J., Hartigan, P. J., Smyth, C. J., and Kapur, V. (1997). Fine-structure molecular epidemiological analysis of Staphylococcus aureus recovered from cows. Epidemiol. Infect. 119, 261-269. doi: 10.1017/S0950268897007802
28. Flemming, H.-C., and Wingender, J. (2010). The biofilm matrix. Nat. Rev. Micro 8, 623-633
29. Giacometti, A., Cirioni, O., Barchiesi, F., and Scalise, G. (2000). In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics. Diagn Microbiol. Infect Dis. 38, 115-118. doi: 10.1016/S0732-8893(00)00175-9
30. Hájek, V. (1976). Staphylococcus intermedius, a new species isolated from animals. Int. J. Syst. Bacteriol. 26, 401-408. doi: 10.1099/00207713-26-4-401
31. Jain, A., and Agarwal, A. (2009). Biofilm production, a marker of pathogenic potential of colonizing and commensal staphylococci. J. Microbiol. Methods 76, 88-92. doi: 10.1016/j.mimet.2008.09.017
32. Kelly, D., McAuliffe, O., Ross, R. P., and Coffey, A. (2012). Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives. Lett. Appl. Microbiol. 54, 286-291. doi: 10.1111/j.1472-765X.2012.03205.x
33. Kneuper, H., Cao, Z. P., Twomey, K. B., Zoltner, M., Jäger, F., Cargill, J. S., et al. (2014). Heterogeneity in ess transcriptional organization and variable contribution of the Ess/Type VII protein secretion system to virulence across closely related Staphylocccus aureus strains. Mol. Microbiol. 93, 928-943. doi: 10.1111/mmi.12707
34. Kong, W., and Lu, T. (2014). Cloning and optimization of a nisin biosynthesis pathway for bacteriocin harvest. ACS Synth. Biol. 3, 439-445. doi: 10.1021/sb500225r
35. Kristian, S. A., Lauth, X., Nizet, V., Goetz, F., Neumeister, B., Peschel, A., et al. (2003). Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J. Infect. Dis. 188, 414-423. doi: 10.1086/376533
36. Lebel, G., Piche, F., Frenette, M., Gottschalk, M., and Grenier, D. (2013). Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics. Peptides 50, 19-23. doi: 10.1016/j.peptides.2013.09.014
37. Livermore, D. M. (2000). Antibiotic resistance in staphylococci. Int. J. Antimicrob. Agents 16(Suppl. 1), S3-S10. doi: 10.1016/S0924-8579(00)00299-5
38. Mataraci, E., and Dosler, S. (2012). In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 56, 6366-6371. doi: 10.1128/AAC.01180-12
39. Molloy, E. M., Field, D., Pm, O. C., Cotter, P. D., Hill, C., and Ross, R. P. (2013). Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity. PLoS ONE 8:e58530. doi: 10.1371/journal.pone.0058530
40. Murayama, N., Nagata, M., Terada, Y., Okuaki, M., Takemura, N., Nakaminami, H., et al. (2013). In vitro antiseptic susceptibilities for Staphylococcus pseudintermedius isolated from canine superficial pyoderma in Japan. Vet. Dermatol. 24, 126-e129. doi: 10.1111/j.1365-3164.2012.01103.x
41. Naghmouchi, K., Le Lay, C., Baah, J., and Drider, D. (2012). Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Res Microbiol 163, 101-108. doi: 10.1016/j.resmic.2011.11.002
42. Okuda, K., Zendo, T., Sugimoto, S., Iwase, T., Tajima, A., Yamada, S., et al. (2013). Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob. Agents Chemother. 57, 5572-5579. doi: 10.1128/AAC.00888-13
43. O'Toole, G. A. (2011). Microtiter dish biofilm formation assay. J. Vis. Exp. 30:2437. doi: 10.3791/2437
44. Otto, M. (2008). Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322, 207-228
45. Paul, N. C., Moodley, A., Ghibaudo, G., and Guardabassi, L. (2011). Carriage of methicillin-resistant Staphylococcus pseudintermedius in small animal veterinarians: indirect evidence of zoonotic transmission. Zoo. Public Health 58, 533-539. doi: 10.1111/j.1863-2378.2011.01398.x
46. Piper, C., Cotter, P. D., Ross, R. P., and Hill, C. (2009a). Discovery of medically significant lantibiotics. Curr. Drug Discov. Technol. 6, 1-18. doi: 10.2174/157016309787581075
47. Piper, C., Draper, L. A., Cotter, P. D., Ross, R. P., and Hill, C. (2009b). A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J. Antimicrob Chemother. 64, 546-551. doi: 10.1093/jac/dkp221
48. Rishi, P., Preet Singh, A., Garg, N., and Rishi, M. (2014). Evaluation of nisin-beta-lactam antibiotics against clinical strains of Salmonella enterica serovar Typhi. J. Antibiot. (Tokyo) 67, 807-811. doi: 10.1038/ja.2014.75
49. Ruscher, C., Lübke-Becker, A., Wleklinski, C.-G., Soba, A., Wieler, L. H., and Walther, B. (2009). Prevalence of Methicillin-resistant Staphylococcus pseudintermedius isolated from clinical samples of companion animals and equidaes. Vet. Microbiol. 136, 197-201. doi: 10.1016/j.vetmic.2008.10.023
50. Scheffers, D. J., and Tol, M. B. (2015). LipidII: just another brick in the wall? PLoS Pathog. 11:e1005213. doi: 10.1371/journal.ppat.1005213
51. Sears, P. M., Smith, B. S., Stewart, W. K., Gonzalez, R. N., Rubino, S. D., Gusik, S. A., et al. (1992). Evaluation of a nisin-based germicidal formulation on teat skin of live cows. J. Dairy Sci. 75, 3185-3190. doi: 10.3168/jds.S0022-0302(92)78083-7
52. Singh, A., Walker, M., Rousseau, J., and Weese, J. S. (2013). Characterization of the biofilm forming ability of Staphylococcus pseudintermedius from dogs. BMC Vet. Res. 9:93. doi: 10.1186/1746-6148-9-93
53. Stepanovic, S., Vukovic, D., Hola, V., Bonaventura, G. D., Djukic, S., CIrkovic, I., et al. (2007). Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115, 891-899. doi: 10.1111/j.1600-0463.2007.apm_630.x
54. Stryjewski, M. E., and Corey, G. R. (2014). Methicillin-resistant Staphylococcus aureus: an evolving pathogen. Clin. Infect. Dis. 58(Suppl. 1), S10-S19. doi: 10.1093/cid/cit613
55. Tong, S. Y., Davis, J. S., Eichenberger, E., Holland, T. L., and Fowler, V. G. Jr. (2015). Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 28, 603-661. doi: 10.1128/CMR.00134-14
56. Tong, Z., Zhang, Y., Ling, J., Ma, J., Huang, L., and Zhang, L. (2014). An in vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalis. PLoS ONE 9:e89209. doi: 10.1371/journal.pone.0089209
57. Viguier, C., Arora, S., Gilmartin, N., Welbeck, K., and Kennedy, R. (2009). Mastitis detection: current trends and future perspectives. Trends Biotechnol. 27, 486-493. doi: 10.1016/j.tibtech.2009.05.004
58. Wu, J., Hu, S., and Cao, L. (2007). Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob. Agents Chemother. 51, 3131-3135. doi: 10.1128/AAC.00629-07
59. Yoo, J. H., Yoon, J. W., Lee, S. Y., and Park, H. M. (2010). High prevalence of Fluoroquinolone-and Methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in veterinary teaching hospital. J. Microbiol. Biotechnol. 20, 798-802
60. Yoon, J. W., Lee, K. J., Lee, S. Y., Chae, M. J., Park, J. K., Yoo, J. H., et al. (2010). Antibiotic resistance profiles of Staphylococcus pseudintermedius isolates from canine patients in Korea. J. Microbiol. Biotechnol. 20, 1764-1768